Total Implantable Central Venous Access Port Implantation in a Hybrid Operating Room: Single Center Results

Purpose: To observe the effect of using Ultrasonography (USG) and X-ray Floroscopy (XrF) on perioperative and postoperative complications in order to optimize catheter position during TIVAP implantation in hybrid operating rooms where surgical sterilization can be effectively provided and to share the retrospective results of our technique. Material and Methods: Patients who underwent Total Implantable Central Venous Access Port Implantation (TIVAP) implantation in our clinic between 01.11.2022 and 31.08.2024 will be retrospectively screened. Electronic patient records will be accessed to collect variables such as age, gender, body mass index (BMI), oncological diagnosis, complications, and duration of TIVAP use. Patients who are not performed by cardiovascular surgeons, who do not have punctures according to USG guidelines, and who do not use XrF will be excluded from the study. In patients who meet the conditions, malposition, pneumothorax, hemothorax will be evaluated in postoperative chest radiographs, the patients' TIVAP usage period until 31.08.2024 will be reached, and the reasons for TIVAP removal will be listed. Results: The study included 112 patients. No patient developed malposition, pneumothorax, venous thrombosis, arterial puncture or acute bleeding. The most common complication that shortened the duration of TIVAP use the most was infection. 70 patients are currently using TIVAP and are under follow-up. Conclusion: This series of 112 patients; The success of XrF and USG in the TIVAP implantation procedure performed by cardiovascular surgeons is shown. The fact that no perprocedural complications and malpositions were observed and the infection rate was low compared to current literature was thought to be related to the fact that TIVAP implantation was performed in operating rooms where USG, XrF could be used and a sterile area could be created for the surgeon.